Spinogenix, Inc. Alternatives & Competitors
12 companies similar to Spinogenix, Inc. — Developing a new class of therapeutics for neurodegenerative and psychiatric dis...
Companies similar to Spinogenix, Inc.
Cognition Therapeutics, Inc.
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
Ophidion
Advancing brain-targeted therapies with precision and innovation for neurodegenerative and...
Rectify Pharma
Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein f...
Passage Bio
Our mission is to improve the lives of patients with neurodegenerative diseases
Rival Readout
Competing with Spinogenix, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Biosplice Therapeutics
Restore health by delivering first-in-class therapies that harness alternative splicing
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
AGY Therapeutics
Pioneering breakthrough treatments for central nervous system diseases through innovative...
Praxis Precision Medicines, Inc.
The era of genetic neuroscience has arrived
Myrobalan Therapeutics
Myro’s mission is to develop first-in-class and best-in-class small molecule drugs for CNS...
Cadent Therapeutics
Pioneering precision neuroscience to restore cognitive and motor function through groundbr...
Bionomics Ltd
Developing novel drug candidates to transform the lives of patients with anxiety and stres...
Disarm Therapeutics
Creating advanced therapeutics to combat axonal degeneration and treat neurological diseas...
About Spinogenix, Inc.
Spinogenix, Inc. is a biotechnology startup focused on developing innovative therapeutics for neurodegenerative and psychiatric diseases. The company's mission is to address the underlying causes of cognitive and motor function declines by regenerating synapses, a unique approach in the field.
Neurodegenerative Diseases, Psychiatric Diseases, Synaptic Loss, Cognitive Function, Motor Function, Therapeutics Development, Small Molecule Drugs, Central Nervous System Disorders, Neurorestorative Therapies, Synaptic Regeneration, Disease-specific Degenerative Processes, SPGs, Molecular Target, Neuroscience Research, Synaptic Restoration
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Spinogenix, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Spinogenix, Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 26 Jul 2024 and 30 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.